Evidence map›Paper›PMID 23339562›Full record

ArticleBMC cancer2013

Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium.

Linda E Kelemen, Elisa V Bandera, Kathryn L Terry, Mary Anne Rossing, Louise A Brinton, Jennifer A Doherty, Roberta B Ness, Susanne Krüger Kjaer, Jenny Chang-Claude, Martin Köbel and 22 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMC cancer, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 3 pooled it
5.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 3 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Dietary intake and ovarian cancer risk: a systematic review.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2014
    Pooled it
  4. Review
  5. Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression Subtypes.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  6. Prevention of Epithelial Ovarian Cancer.Cold Spring Harbor perspectives in medicine · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2016
    Review
  15. Potential impact of (rs 4645878) BAX promoter -248G>A and (rs 1042522) TP53 72Arg>pro polymorphisms on epithelial ovarian cancer patients.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2016
    Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 18 institutions in 7 countries.

Linda E KelemenDepartment of Population Health Research, Alberta Health Services-Cancer Care, AB, Canada. LKelemen@post.harvard.edu
Elisa V Bandera
Kathryn L Terry
Mary Anne Rossing
Louise A Brinton
Jennifer A Doherty
Roberta B Ness
Susanne Krüger Kjaer
Jenny Chang-Claude
Martin Köbel
Galina Lurie
Pamela J Thompson
Michael E Carney
Kirsten Moysich
Robert Edwards
Clare Bunker
Allan Jensen
Estrid Høgdall
Daniel W Cramer
Allison F Vitonis
Sara H Olson
Melony King
Urmila Chandran
Jolanta Lissowska
Montserrat Garcia-Closas
Hannah Yang
Penelope M Webb
Joellen M Schildkraut
Marc T Goodman
Harvey A Risch
Australian Ovarian Cancer Study Group and Australian Cancer Study (Ovarian Cancer)
Ovarian Cancer Association Consortium
University of Hawaiʻi at Mānoa · USBrigham and Women's Hospital · USFred Hutch Cancer Center · USAlberta Health Services · CAGerman Cancer Research Center · DEInstitute of Cancer Research · GBUniversity of Pittsburgh · USCedars-Sinai Medical Center · USDanish Cancer Society · DKDuke Medical Center · USHarvard University · USMemorial Sloan Kettering Cancer Center · USNational Cancer Institute · USRoswell Park Comprehensive Cancer Center · USRutgers Cancer Institute · USThe Maria Sklodowska-Curie National Research Institute of Oncology · PLUniversity of Copenhagen · DKYale University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Hormone-Related CancersZIACP010126 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI GIERACH, GRETCHEN · 2009 to 2025
$103.5M
Novel Serum, Plasma, and Urine Biomarkers of Ovarian CanP50CA105009 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI CRAMER, DANIEL WILLIAM · 2004 to 2010
$13.3M
The Molecular Epidemiology Of Ovarian CancerR01CA076016 · NCI · DUKE UNIVERSITY · PI SCHILDKRAUT, JOELLEN M. · 1998 to 2010
$6.2M
OVARIAN CANCER RISK AND HYPERGONADOTROPIC HYPOGONADISMR01CA054419 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI CRAMER, DANIEL WILLIAM · 1992 to 2007
$5.9M
COLLABORATIVE STUDY OF OVARIAN CANCER IN TWO RISK GROUPSR01CA058598 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI GOODMAN, MARC T · 1993 to 2012
$4.6M
Epidemiology of Ovarian Cancer:New HypothesesR01CA087538 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ROSSING, MARY ANNE · 2002 to 2006
$3.5M
Steroid Hormone Genes and Ovarian Cancer RiskR01CA112523 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ROSSING, MARY ANNE · 2006 to 2010
$3.3M
ESTROGEN, DIET, GENETICS AND ENDOMETRIAL CANCERR01CA083918 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI OLSON, SARA H · 2001 to 2005
$2.5M
SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS PROGRAMN01PC067001 · PC · UNIVERSITY OF HAWAII AT MANOA · PI GOODMAN, MARC T · 1996 to 2000
$1.6M
CASE CONTROL STUDY OF OVARIAN CANCER HORMONAL ETIOLOGYR01CA074850 · NCI · YALE UNIVERSITY · PI RISCH, HARVEY A · 1997 to 2002
$965k
Phytoestrogens, alcohol, and endometrial cancer riskK07CA095666 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI BANDERA, ELISA V · 2003 to 2007
$672k
CIHR MSH-87734Intramural NIH HHSNCI NIH HHS K07 CA095666NCI NIH HHS K22 CA138563NCI NIH HHS K22CA138563NCI NIH HHS N01 CN-55424NCI NIH HHS N01 PC-67001NCI NIH HHS P30 CA008748NCI NIH HHS P50 CA105009NCI NIH HHS R01 CA054419NCI NIH HHS R01 CA074850NCI NIH HHS R01CA074850NCI NIH HHS R01 CA076016NCI NIH HHS R01 CA080742NCI NIH HHS R01 CA087538NCI NIH HHS R01 CA112523NCI NIH HHS R01CA54419NCI NIH HHS R01 CA58598NCI NIH HHS R01 CA61107NCI NIH HHS R01 CA76016NCI NIH HHS R01 CA83918NCI NIH HHS R01 CA87538
6 · The paper itself

Abstract

backgroundStudies evaluating the association between alcohol intake and ovarian carcinoma (OC) are inconsistent. Because OC and ovarian borderline tumor histologic types differ genetically, molecularly and clinically, large numbers are needed to estimate risk associations.

methodsWe pooled data from 12 case-control studies in the Ovarian Cancer Association Consortium comprising 5,342 OC cases, 1,455 borderline tumors and 10,358 controls with quantitative information on recent alcohol intake to estimate odds ratios (OR) and 95% confidence intervals (CI) according to frequencies of average daily intakes of beer, wine, liquor and total alcohol.

resultsTotal alcohol intake was not associated with all OC: consumption of >3 drinks per day compared to none, OR=0.92, 95% CI=0.76-1.10, P trend=0.27. Among beverage types, a statistically non-significant decreased risk was observed among women who consumed >8 oz/d of wine compared to none (OR=0.83, 95% CI=0.68-1.01, P trend=0.08). This association was more apparent among women with clear cell OC (OR, 0.43; 95% CI, 0.22-0.83; P trend=0.02), although based on only 10 cases and not statistically different from the other histologic types (P value for statistical heterogeneity between histologic types = 0.09). Statistical heterogeneity of the alcohol- and wine-OC associations was seen among three European studies, but not among eight North American studies. No statistically significant associations were observed in separate analyses evaluating risk with borderline tumors of serous or mucinous histology. Smoking status did not significantly modify any of the associations.

conclusionsWe found no evidence that recent moderate alcohol drinking is associated with increased risk for overall OC, or that variation in risk is associated strongly with specific histologic types. Understanding modifiable causes of these elusive and deadly cancers remains a priority for the research community.

Indexed as

Alcohol DrinkingAlcoholic BeveragesAustraliaCanadaCarcinomaCase-Control StudiesEuropeFemaleHumansIncidenceLogistic ModelsMultivariate AnalysisOdds RatioOvarian NeoplasmsRisk AssessmentRisk Factors

Identifiers

PMID23339562
PMCPMC3568733
OpenAlexW2121066598

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.